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EDITORIALMajor advances in surgical techniques and medical care
have brought exciting change to the outcomes of children
treated for complex congenital heart disease. Hypoplastic
left heart syndrome, for example, was uniformly fatal only
30 years ago, but now has a 5-year survival of approximately
70%.1-4 Although the survival for those with surgically
repaired complex congenital heart defects has markedly
improved, associated morbidities remain high. The neurode-
velopmental outcomes of infants and children requiring mul-
tiple cardiac operations in childhood are among the major
concerns of those who care for patients with congenital heart
disease.
Deep hypothermic circulatory arrest (DHCA), an adjunc-
tive surgical technique that requires cooling the patient to
18C and ceasing all blood flow to the entire body including
the brain, has until recently been the standard intraoperative
procedure used to perform aortic arch reconstruction in in-
fants and young children. The development of DHCA in
the early 1970s was a breakthrough that allowed for the op-
erative treatment of many lesions previously not amenable to
repair in neonates. Unfortunately, although still a mainstay
in congenital heart surgery, DHCA is associated with the po-
tential for poor neurodevelopmental outcomes.5-7
ALTERNATIVE PERFUSION TECHNIQUES
Regional cerebral perfusion (RCP), a recently described
alternative to DHCA, involves directing blood flow to the
central nervous system throughout aortic arch reconstruc-
tion. RCP, first described by Asou and colleagues8 in 1996
as an alternative to DHCA, is hypothesized to be potentially
neuroprotective relative to DHC. Since 2000, multiple case
series of patients managed with RCP have been pub-
lished.9,10 In a piglet model, RCP was found superior to
DHCA on neurobehavioral and histopathologic scores, al-
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sults from human trials comparing RCP with DHCA have
not shown a similar benefit. Data from a single institution
randomized trial that we conducted demonstrated no clear
difference between RCP and DHCA on developmental sta-
tus 1 year after Norwood surgery using the Bayley Scales
of Infant Developmental.12 Similarly, 2 additional studies
using historical or nonrandomized contemporary controls
also failed to demonstrate a benefit in developmental testing
or magnetic resonance imaging-detected brain injury when
RCP was compared with DHCA.13,14
In addition to RCP, another technique that has been de-
scribed for use in aortic arch repair is intermittent perfusion
(IP). This procedure, which involves brief periods of cere-
bral perfusion during DHCA, has been shown to ameliorate
the negative metabolic and ultrastructural effects of DHCA
in a porcine model, but again, no empirical evidence exists
to support such a benefit in humans.15 Although the use of
IP seems to be limited, anecdotal reports in the literature sug-
gest that RCP is now used widely among cardiothoracic sur-
geons who perform aortic arch reconstruction. Yet, despite
the uncertainty over the optimal perfusion technique for
neonatal aortic arch repair, true evidence of the equipoise
necessary to support a randomized clinical trial is lacking.
Because of the lack of published data on the prevalence of
RCP and IP use in contrast with DHCA and on the underly-
ing reasons for choosing these newer adjuvant procedures
over DHCA, we conducted a survey among congenital heart
surgeons who perform neonatal arch reconstruction to eval-
uate the rates of use of these techniques and to determine the
reasons that underlie that treatment decision.
PERFUSION TECHNIQUES IN NEONATAL ARCH
RECONSTRUCTION: A SURVEY OF
PREFERENCES AND ATTITUDES
Congenital heart surgeons of North America were sur-
veyed on the use of a variety of perfusion techniques during
aortic arch reconstruction operations. Additional questions
were aimed at determining the level of evidence-based med-
icine that was available to support their choice. Approval for
the studywas granted by theUniversity ofMichiganMedical
School Institutional Review Board. The Society of Thoracic
Surgeons’ Congenital Heart Surgeons Workforce Database
was queried for all cardiac surgeons within North America
who perform congenital heart operations. This list of sur-
geons was cross-referenced to the United States and Canada
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tory—August 2006 from the American Academy of Pediat-
rics. A survey was developed to measure the frequency of
various perfusion techniques and to assess the reasoning be-
hind the choices made. Requests to participate were sent via
e-mail, and the Internet-based survey was conducted using
Websurveyer (www.websurveyer.com). After an initial
question confirming that the surgeon did perform neonatal
aortic arch reconstruction, they were asked to complete the
brief survey. The respondents were queried on whether
they used DHCA, RCP, or IP for neonatal arch repair exclu-
sively, routinely, selectively, or not at all. The definition of
each procedure, respectively, was provided in the instruc-
tions that preceded each question item. Respondents were
then asked the basis for their decision on the choice of tech-
nique. The decision response items were designed to approx-
imate the standard levels of evidence-based support: (1)
definitive literature, (2) suggestive literature, (3) opinions
of experts, (4) personal experience, (5) no alternative, and
(6) other (with text field for description). Respondents who
reported using any of the techniques either routinely or selec-
tively were then queried about the factors that influenced
their decision to use a method for a particular case. Response
items were (1) length of procedure, (2) type of procedure, (3)
patient anatomy, (4) patient weight, (5) patient age, and (6)
other (with a text field for description). More than 1 response
choice was allowed for this latter question.
SURVEY RESULTS
From the roster of 251 surgeons identified as potentially
eligible to participate, not including the 15 surgeons for
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FIGURE 1. Proportion of surgeons using each perfusion type. DCHA,
Deep hypothermic circulatory arrest; RCP, regional cerebral perfusion;
IP, intermittent perfusion.804 The Journal of Thoracic and Cardiovascular Surwhom we were unable to find a valid e-mail address, we suc-
cessfully recruited 140 of 212 (66%).
RATES OF USE
The relative proportion of use by perfusion technique is
shown in Figure 1. Twenty percent of respondents reported
routine or exclusive use of DHCA during aortic arch repair,
compared with 50% of respondents who reported routine
or exclusive use of RCP. In contrast, none of the respond-
ing surgeons reported IP use on a routine or exclusive basis.
In fact, 70% of respondents reported not using IP at all,
compared with 26% and 17% not using DHCA or RCP,
respectively.
SUPPORT FOR USING ATECHNIQUE
Table 1 shows the percentages by response category for
why surgeons choose DHCA or RCP either exclusively or
routinely (combined). Although RCP was more frequently
used regularly than DHCA, the proportion who reported
a definitive literature supporting its use was considerably
lower for RCP (5.7%) than for DHCA (17.9%). The 2
response items most frequently endorsed for RCP was sug-
gestive literature (71.4%) and personal experience
(64.3%). For DHCA, the 2 most frequent endorsements
were personal experience (75%) and opinions of experts
(57%). Results were similar for those reporting using
DHCA or RCP selectively (Table 2). For those answering
‘‘not at all,’’ the reasons for not using DHCA, RCP, or IP
are shown in Table 3.
FACTORS INFLUENCING THE DECISION TO USE
ATECHNIQUE
For respondents who reported using more than 1 tech-
nique (ie, answered either ‘‘routinely’’ or ‘‘selectively’’),
the relative distribution of decision factors endorsed to apply
a particular perfusion method is shown in Table 4. The fac-
tors influencing choice of procedure were similar for DHCA
and RCP, with the length of procedure, type of procedure,
and patient anatomy being most frequently cited. Length
of procedure and patient age were more frequently identified
as factors influencing use of IP than either DHCA or RCP.
TABLE 1. Reasons for using a technique exclusively or routinely
DHCA (n ¼ 28) RCP (n ¼ 70)
n % n %
Definitive literature 5 17.9% 4 5.7%
Suggestive literature 11 39.3% 50 71.4%
Opinions of experts 16 57.1% 32 45.7%
Personal experience 21 75.0% 45 64.3%
No alternative 14 50.0% 9 12.9%
Other 1 3.6% 7 10.0%
DCHA, Deep hypothermic circulatory arrest; RCP, regional cerebral perfusion. Re-
spondents could select all that applied (eg, rows are not mutually exclusive).gery c April 2009
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LINFERENCES REGARDING THE RATES OF USE
AND SUPPORT FOR USING ATECHNIQUE
The results of this survey demonstrate the current rates of
use of the 3 perfusion techniques available for neonatal aor-
tic arch reconstruction. There is clearly appropriate concern
regarding the safety of DHCA, with 80% of respondents
only using DHCA selectively or avoiding it all together.
This concern would seem warranted by the relatively large
body of literature implicating DHCA in poor neurodevelop-
mental outcomes in both human and animal studies.5-7,9 In
response, half of the surgeons performing neonatal arch
reconstructions endorsed RCP as their perfusion technique
of choice.
RATES OF USE
There are several interesting observations that can be
made from the data from this survey study. First, a greater
percentage of surgeons apparently believe that DHCA is in-
herently worse than RCP. The results demonstrated that
54% of respondents use DHCA only selectively and 26%
not at all, compared with 33% and 17%, respectively, for
RCP. These data suggest that a greater number of surgeons
think that DHCA is to be avoided when possible or not used
at all in favor of RCP. In addition, this survey demonstrates
that the use of RCP is widespread. Twenty percent of re-
spondents use DHCA either exclusively or routinely,
whereas 50% use RCP exclusively or routinely, suggesting
they believe that their method of choice represents ‘‘best
practice’’ or ‘‘standard of care.’’
SUPPORT FOR USING ATECHNIQUE
For those respondents answering ‘‘exclusively’’ or ‘‘rou-
tinely,’’ the most common reason cited for using DHCAwas
‘‘personal experience,’’ followed by ‘‘expert opinion.’’ For
RCP, the most common reason for using the technique ex-
clusively or routinely was a ‘‘suggestive literature,’’ fol-
lowed by ‘‘personal experience.’’
Similarly, for surgeons using RCP or DHCA selectively,
the most common reason cited by respondents for the use of
DHCA was ‘‘personal experience’’ and for the use of RCP
was ‘‘suggestive literature.’’ These data would appear para-
TABLE 2. Reasons for using a technique selectively
DHCA (n ¼ 76) RCP (n ¼ 46)
n % n %
Definitive literature 17 22.4% 1 2.2%
Suggestive literature 34 44.7% 36 78.3%
Opinions of experts 31 40.8% 23 50.0%
Personal experience 44 57.9% 30 65.2%
No alternative 11 14.5% 2 4.3%
Other 12 15.8% 3 6.5%
DCHA, Deep hypothermic circulatory arrest; RCP, regional cerebral perfusion. Re-
spondents could select all that applied (eg, rows are not mutually exclusive).The Journal of Thoracic anddoxical, because the body of literature is larger for DHCA
than for RCP. However, this finding could be explained by
the fact that DHCA is a more long-standing technique,
with which most congenital surgeons have extensive famil-
iarity and are therefore comfortable with their personal expe-
rience. With RCP being in use for a shorter period of time
than DHCA, there is less personal experience, and thus sur-
geons may prefer to look to the literature to support their de-
cision.
For those surgeons responding that theydidnot usea partic-
ular technique at all, the most common reason given for both
DHCA and RCP was ‘‘suggestive literature.’’ For IP, the
most common reason given was ‘‘personal experience.’’
These citations of ‘‘suggestive literature’’ for DHCA and
RCP would seem expected because there are numerous stud-
ies, including the Boston Circulatory Arrest Trial, outlining
the risks associated with DHCA,5-7,9 as well as the aforemen-
tioned studies failing to show a benefit of RCP comparedwith
DHCA.12-14 In regard to IP, with the exception of the single
animal study byLangley and associates,15 there is no other lit-
erature available to our knowledge, perhaps explaining why
most commonly ‘‘personal experience’’ (or lack thereof)
was cited as the reason for avoiding the technique.
INFERENCES REGARDING THE ROLE OF
EVIDENCE-BASED MEDICINE IN OUR PRACTICE
From these data, one may also make inferences regarding
the current role of evidence-based medicine in clinical
TABLE 3. Reasons for not using a technique
DHCA (n ¼ 36) RCP (n ¼ 24) IP (n ¼ 98)
n % n % n %
Definitive literature 1 2.8% 1 4.2% 2 2.0%
Suggestive literature 25 69.4% 17 70.8% 21 21.4%
Opinions of experts 11 30.6% 5 20.8% 15 15.3%
Personal experience 12 33.3% 12 50.0% 64 65.3%
Other 5 13.9% 1 4.2% 14 14.3%
DCHA, Deep hypothermic circulatory arrest; RCP, regional cerebral perfusion; IP, in-
termittent perfusion. Respondents could select all that applied (eg, rows are not mutu-
ally exclusive).
TABLE 4. Factors influencing the decision to select a particular
technique
DHCA (n ¼ 90) RCP (n ¼ 97) IP (n ¼ 42)
n % n % n %
Length of procedure 63 70.0% 75 77.3% 41 97.6%
Type of procedure 78 86.7% 82 84.5% 37 88.1%
Patient anatomy 81 90.0% 86 88.7% 34 81.0%
Patient weight 46 51.1% 44 45.4% 18 42.9%
Patient age 31 34.4% 34 35.1% 20 47.6%
Other 8 8.9% 3 3.1% 0 -
DCHA, Deep hypothermic circulatory arrest; RCP, regional cerebral perfusion; IP, in-
termittent perfusion. Respondents could select all that applied (eg, rows are not mutu-
ally exclusive).Cardiovascular Surgery c Volume 137, Number 4 805
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Ldecision making. At least as pertains to choosing the optimal
perfusion techniques for neonatal arch reconstruction, the
surgeons responding to the survey were willing to accept
a rather low level of evidence-based medicine to adopt
a new technique. There also seems to be a rather low bar
for surgeons to define literature as ‘‘supportive’’ or ‘‘defin-
itive.’’ Whether citing the reasons for choosing DHCA
(57% ‘‘suggestive’’ or ‘‘definitive’’ literature) or RCP
(77% ‘‘suggestive’’ or ‘‘definitive’’ literature), we as sur-
geons believe there is strong support for what we do, even
though a review of the literature comparing the 2 techniques
does not bear out this belief. There is only 1 randomized con-
trolled trial, and this study did not demonstrate a difference
in developmental testing between RCP and DHCA.12 The
remaining 2 comparative studies13,14 and the numerous
case series are not of sufficient methodologic quality to de-
fine the role of RCP based on the Jadad quality assessment
scale16 or standard levels of evidence-based medicine. Fur-
thermore, recent literature on neurocognitive outcomes in
patients undergoing congenital heart surgery would suggest
that genetic polymorphisms and hematocrit levels on cardio-
pulmonary bypass may have a greater impact than duration
of DHCA.17-19 Thus, it is unknown whether the trend for us-
ing RCP is beneficial, detrimental, or of no added conse-
quence to the patient.
CONCLUSIONS
On the basis of the results of this survey, aswell as a review
of the literature, it is clear that the optimal perfusion method
for aortic arch reconstruction remains unknown and that
equipoise exists among surgeons caring for neonates requir-
ing aortic arch reconstruction. The need to improve our un-
derstanding of and to base clinical management decisions
on solid evidence-based medicine is obvious. The impetus
for a multi-institutional randomized clinical trial comparing
DHCA and RCP would seem equally as clear.
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